Tragara Pharmaceuticals

📍 Carlsbad, United States🗓 Founded 2007💰 Last funded Sep 2014
Biotechnology🌐 tragarapharma.com
Website LinkedIn
Tragara Pharmaceuticals, Inc. is a privately held pharmaceutical company based in San Diego, Calif. The company is focused on the clinical and commercial development of proprietary medicines for the treatment of cancer. TG02 is a unique, oral multi-kinase inhibitor which combines the benefits of inhibiting important cyclin dependent kinases equipotently with JAK2, FLT3, and ERK5 inhibition. TG02 exerts its antitumor activity via its potent CDK9 inhibition, which leads to the depletion of key survival proteins, such as Mcl-1, resulting in p53-independent apoptosis of a wide range of tumor cells. Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics. Its investors include: Domain Associates, Mitsubishi International Corporation, Morganthaler Ventures, and ProQuest Investments. Tragara strives to provide much-needed therapies that will contribute to patient health through better survival and an increase in the quality of life. For more information, visit www.tragarapharma.com.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Tragara Pharmaceuticals?
Tragara Pharmaceuticals has 1 investors on record on gritt.io and 1 late-stage investors.
When did Tragara Pharmaceuticals last raise funding?
The most recent investment in Tragara Pharmaceuticals recorded on gritt.io was in September 2014.
When was Tragara Pharmaceuticals founded?
Tragara Pharmaceuticals was founded in 2007.
What industry is Tragara Pharmaceuticals in?
Tragara Pharmaceuticals operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Tragara Pharmaceuticals based?
Tragara Pharmaceuticals is headquartered in Carlsbad, United States.